DOD, HHS Awards a $35.1M contract to LightDeck Diagnostics to increase production of its 5-Minute point-of-care tests for COVID-19
By: Colorado BioScience Association Date: 07/08/2021
On July 8, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $35.1 million contract to LightDeck Diagnostics to increase its manufacturing capacity, and is specifically aimed to LightDeck’s upcoming ultra-rapid COVID-19 Ultra-Rapid Antigen and Total Antibody tests. With the funds, LightDeck will be able to increase its Colorado-based production capacity, from 50 thousand tests per month to 1.0 million per month, by September of 2022.
Testing quickly, accurately, and frequently is critical for preventing the further spread of COVID-19, especially as we begin to lift up restrictions on public gatherings. LightDeck’s point-of-care five-minute tests will enable results within the span of a doctor’s appointment, lessening the burden of unnecessary quarantines and improving timeliness of diagnosis. LightDeck CEO, Chris Myatt remarks, “Our mission is to democratize access to diagnostics solutions that deliver speed without compromising accuracy. We’re honored to receive this contract from the DOD and HHS to drive our mission forward and continue to improve the state of our public health.”
The DOD’s Defense Assisted Acquisition (DA2) Cell led this effort in coordination with the Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT). HHS’ Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response, funded this effort through the Health Care Enhancement Act (HCEA) to support domestic industrial base expansion for critical medical resources.
To learn more about LightDeck or BARDA’s COVID-19 response efforts, visit https://lightdeckdx.com/ or www.medicalcountermeasures.gov/.
To find out more, visit the LightDeck press release.